These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1215739)

  • 1. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on the use of ethyl apovincaminate in affections of the eyeground.
    Brooser G; Anda L; Domán J
    Arzneimittelforschung; 1976; 26(10a):1973-5. PubMed ID: 1037226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strong delayed-action pervincamine in general medicine].
    Warembourg H; Ketelers JY
    Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials of using Cavinton in the form of intravenous infusion in the treatment of macular degeneration].
    Gerkowicz K; Toczołowski J; Jedrzejewski D; Jankowska I; Szponar B
    Klin Oczna; 1987 Mar; 89(3):95-6. PubMed ID: 3309450
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advantages of delayed-action Pervincamine Forte in the prevention of altitude sickness].
    Adenis L
    Lille Med; 1978 May; 23(5 Suppl 1):382-3. PubMed ID: 682848
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of vascular retinal lesions with Cavinton (author's transl)].
    Oláh Z; Potocký M
    Cesk Oftalmol; 1981 Jan; 37(1):19-23. PubMed ID: 7471250
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug delivery to the back of the eye.
    Kompella UB
    Arch Soc Esp Oftalmol; 2007 Nov; 82(11):667-8; 669-70. PubMed ID: 17979032
    [No Abstract]   [Full Text] [Related]  

  • 10. [Retrospective analysis of the effect of vinpocetine infusion in ophthalmologic disorders].
    Végh S; Szikszay E; Bönöczk P; Cserjés Z; Kiss G
    Orv Hetil; 2006 Dec; 147(49):2361-5. PubMed ID: 17228515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Report on the use of piribedil in vascular and hemorrhagic disease of the posterior pole of the eyeball].
    De Molfetta V; Lauri G
    Minerva Med; 1976 May; 67(26):1696-7. PubMed ID: 934522
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the anti-hypoxia agent vincamine in disorders of the blood supply in the eye].
    Hackmann F
    Med Klin; 1979 Oct; Suppl():57-60. PubMed ID: 542171
    [No Abstract]   [Full Text] [Related]  

  • 13. [Delayed-action peruincamine forte in geriatrics].
    Denceux P
    Lille Med; 1976 Sep; 21(7 Suppl 3):606-9. PubMed ID: 994690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Report of a trial with Pervincamine Forte Retard in 50 cases of various otological disorders].
    Oudot J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 May; 27(5):361-5. PubMed ID: 149837
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis.
    Imre G
    Ther Hung; 1986; 34(2):84-6. PubMed ID: 3449973
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiographic study of the action of pervincamine on cerebral circulation].
    Baiano G; Elefante R; Granata F; Graziussi G
    Acta Neurol (Napoli); 1974 Mar; 29(2):185-9. PubMed ID: 4848048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Irrigation system "Meturakol" in the treatment of dystrophic processes of the posterior eye segment].
    Sidorenko EI; Podyninogin NV
    Vestn Oftalmol; 2000; 116(4):30-1. PubMed ID: 11031874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pervincamine in O.R.L].
    Pech A; Gitenet P
    Ann Otolaryngol Chir Cervicofac; 1972; 89(7):469-74. PubMed ID: 4539305
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spasmolytic, vasodilator and hypotensive drugs in ophthalmology].
    Margolis MG
    Vestn Oftalmol; 1980; (1):62-5. PubMed ID: 6989088
    [No Abstract]   [Full Text] [Related]  

  • 20. New ocular therapeutics: a view from the patenting perspective.
    Mucke HA
    IDrugs; 2007 Jan; 10(1):37-41. PubMed ID: 17187313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.